CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-31 | Potter Stephen W Executive Vice President | Grant or award | +921 | $3.20 | $3K | 14,016 |
| 2014-08-01 | Potter Stephen W Executive Vice President | Grant or award | +6,303 | 12,835 | ||
| 2014-08-01 | Potter Stephen W Executive Vice President | Grant or award · Stock Option (right to purchase) | +25,000 | 25,000 | ||
| 2014-06-30 | Potter Stephen W Executive Vice President | Grant or award | +532 | $5.54 | $3K | 6,532 |
| 2014-01-02 | Potter Stephen W Executive Vice President | Grant or award · Stock Option (right to purchase) | +35,000 | 35,000 | ||
| 2013-07-15 | Potter Stephen W Executive Vice President | Grant or award · Stock Option (right to purchase) | +30,000 | 30,000 | ||
| 2013-02-11 | Potter Stephen W Director | Grant or award | +60,000 | 60,000 | ||
| 2013-02-11 | Potter Stephen W Director | Grant or award · Stock Option (right to purchase) | +93,500 | 93,500 |
Page 1 of 1 · 8 trades